Which sedation drug is safer for mom and baby during C-Section?

NCT ID NCT07676955

Completed Symptom relief Sponsor: Haseki Training and Research Hospital Source: ClinicalTrials.gov ↗

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This study compares two medications—dexmedetomidine and low-dose ketamine—given as a single dose before a planned C-section under spinal anesthesia. Both groups then receive a steady infusion of dexmedetomidine to keep them comfortable. Researchers will measure how well each drug sedates the mother, her blood pressure and heart rate, satisfaction scores, and the baby's health right after birth. The goal is to find which approach offers better comfort with fewer side effects for both mother and newborn.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Dexmedetomidine and ketamine
What this could lead to: If one drug proves better, it could improve comfort and safety for mothers undergoing planned C-sections.
What could go wrong: This is a small, early-phase trial (80 people) comparing two existing drugs, so results may not apply broadly or show major differences.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CESAREAN BIRTH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CESAREAN BIRTH SEDATION SPINAL ANESTHESIA

Contacts and locations

Locations

Sultangazi Haseki Training and Research Hospital

Istanbul, Sultangazi, 34265, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.